Mastering Two-Stage Hip Reimplantation for Periprosthetic Joint Infection

Introduction and Epidemiology

Hip reimplantation refers to the insertion of a new prosthesis following the removal of an original, infected total hip arthroplasty (THA) or hemiarthroplasty. Periprosthetic joint infection (PJI) remains one of the most challenging complications in adult reconstructive surgery, demanding significant healthcare resources and imposing substantial morbidity on the patient. Reimplantation may be executed as a single-stage or two-stage procedure, utilizing cemented or uncemented components depending on host bone stock, organism virulence, and surgeon preference.

The epidemiological burden of PJI is significant. The prevalence of infection ranges from 0.7% to 2% following primary hip arthroplasty and elevates to 3% to 4% following revision procedures. The microbiological profile of infected total hip replacements is predominantly Gram-positive, with Staphylococcus aureus and Staphylococcus epidermidis being the most frequently isolated organisms. Gram-negative bacteria and polymicrobial infections represent a smaller but highly challenging subset, complicated by an increasing prevalence of multidrug-resistant organisms such as Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE).

The pathogenesis of PJI is fundamentally driven by the formation of a bacterial biofilm. Planktonic bacteria adhere to the inert surface of the prosthesis and synthesize an extracellular polymeric substance (EPS). This biofilm matrix protects the sessile bacteria from both the host immune response and systemic antimicrobial therapy. The recalcitrance of biofilm necessitates the physical removal of the infected implants in chronic scenarios.

Infected prostheses are classically categorized using the Tsukayama classification system:
* Type I: Positive intraoperative cultures in an otherwise grossly normal joint.
* Type II: Early postoperative infection occurring within 4 weeks of the index arthroplasty.
* Type III: Acute hematogenous infection occurring in a previously well-functioning joint with less than 4 weeks of symptoms.
* Type IV: Late chronic infections presenting with greater than 4 weeks of symptoms.

Patients with unexpected positive intraoperative cultures (Type I) may initially be managed with targeted systemic antibiotics. Type II and Type III infections are frequently amenable to Debridement, Antibiotics, and Implant Retention (DAIR), provided the modular components are exchanged. Type IV chronic infections mandate the removal of all implants, radical debridement, and subsequent reimplantation due to the mature, impenetrable nature of the established biofilm.

Surgical Anatomy and Biomechanics

A thorough understanding of the surgical anatomy and the altered biomechanics in the setting of previous surgery, bone loss, and infection is critical for successful reimplantation.

Surgical Approaches

Hip reimplantation surgery is predominantly performed via the posterolateral or direct lateral (transgluteal) approaches. The choice of approach is often dictated by the prior surgical incisions, the location of existing hardware, and the anticipated need for extensile exposure.

The posterolateral approach provides excellent exposure of the proximal femur and acetabulum. However, the sciatic nerve is at significant risk, particularly in the revision setting where extensive scar tissue distorts normal fascial planes. In patients with severe arthrofibrosis or distorted anatomy, formal neurolysis and exposure of the sciatic nerve may be required before proceeding with explantation. The sciatic nerve typically emerges deep and inferior to the piriformis muscle, passing superficial to the obturator internus and gemelli complex. Surgeons must remain cognizant of anatomical variations; in approximately 15% to 20% of patients, the nerve or its common fibular division may emerge proximal to, or directly through, the piriformis muscle belly.

The direct lateral approach offers a lower dislocation rate but risks iatrogenic injury to the abductor mechanism. The superior gluteal nerve innervates the gluteus medius, gluteus minimus, and tensor fasciae latae. It courses approximately 5 cm proximal to the tip of the greater trochanter. Proximal extension of the split in the gluteus medius must be strictly limited to avoid denervation of the anterior abductor complex, which would result in a devastating postoperative Trendelenburg gait.

To facilitate component extraction and subsequent reimplantation, either approach may be combined with an Extended Trochanteric Osteotomy (ETO). The ETO provides unparalleled, extensile access to the diaphyseal femur, aids in the safe extraction of well-fixed cemented or porous-coated stems, and allows for direct visualization of the distal canal for subsequent stem bypass.

Acetabular Safe Zones

During acetabular reconstruction, the compromised host bone stock frequently necessitates supplemental screw fixation. The Wasielewski quadrant system dictates the safe placement of these screws to avoid catastrophic neurovascular injury. The acetabulum is divided by two lines: a line from the anterior superior iliac spine through the center of the acetabulum, and a perpendicular line bisecting the acetabulum.
* Posterior Superior Quadrant: The safest zone. Screws placed here enter the dense bone of the sciatic buttress.
* Posterior Inferior Quadrant: Safe, but care must be taken to avoid overpenetration which endangers the sciatic nerve and internal pudendal vessels.
* Anterior Superior Quadrant: Danger zone. Risk of injury to the external iliac artery and vein.
* Anterior Inferior Quadrant: Danger zone. Risk of injury to the obturator nerve and vessels.

Biomechanical Considerations

Reimplantation must restore the hip center of rotation, femoral offset, and leg length. Proximal migration of the hip center increases joint reactive forces and decreases abductor efficiency. In the setting of massive uncontained acetabular defects (Paprosky Type III), the surgeon must utilize highly porous augments, cages, or cup-cage constructs to bridge the defect and lateralize the hip center to its anatomic location. Femoral reconstruction must bypass the most distal cortical defect by a minimum of two cortical diameters to prevent periprosthetic fracture and ensure immediate axial and rotational stability.

Indications and Contraindications

The management of PJI requires a multidisciplinary approach, balancing the eradication of infection with the restoration of biomechanical function. The decision algorithm relies heavily on the chronicity of the infection, host immune status, and the specific isolated pathogen.

The two-stage exchange arthroplasty remains the gold standard in North America for chronic PJI. It involves the removal of all implants, rigorous debridement, placement of an antibiotic-loaded polymethylmethacrylate (PMMA) spacer, a period of systemic antimicrobial therapy, and subsequent reimplantation. Single-stage exchange (direct reimplantation) is gaining traction in select European centers but is strictly reserved for hosts with healthy soft tissues, known highly susceptible organisms, and minimal bone loss.

Indications for Surgical Strategies in Periprosthetic Joint Infection

Pre Operative Planning and Patient Positioning

The preoperative evaluation of a patient with suspected PJI requires meticulous attention to both the clinical history and objective diagnostic criteria.

Clinical Evaluation and Diagnostics

The main presenting symptom of patients with a periprosthetic infection is persistent, insidious pain, often present at rest and during the night. The presence of a draining sinus tract communicating with the joint space is pathognomonic for PJI.

Diagnosis is established using the Musculoskeletal Infection Society (MSIS) or International Consensus Meeting (ICM) criteria. The initial workup mandates the assessment of serum Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP). If inflammatory markers are elevated, a diagnostic joint aspiration is required. Synovial fluid analysis should include a total white blood cell (WBC) count, polymorphonuclear (PMN) percentage, and aerobic/anaerobic cultures held for 14 days to capture indolent organisms like Cutibacterium acnes. A synovial WBC count greater than 3,000 cells/µL or a PMN percentage greater than 80% is highly suggestive of chronic PJI. Biomarkers such as synovial alpha-defensin and leukocyte esterase provide additional diagnostic specificity.

Imaging and Templating

Standard orthogonal radiographs (Anteroposterior pelvis, AP and lateral of the affected hip) are scrutinized for signs of component loosening, endosteal scalloping, or periosteal reaction. Computed Tomography (CT) is invaluable for assessing acetabular bone loss (evaluating the integrity of the anterior and posterior columns, medial wall, and superior dome) and planning for augments or custom triflange constructs.

Preoperative templating must account for the anticipated bone loss following explantation. The surgeon must have a comprehensive armamentarium available, including explantation tools (trephines, flexible osteotomes, ultrasonic cement removal devices), various spacer molds, and revision implant systems (modular fluted tapered stems, highly porous jumbo cups).

Patient Positioning

The patient is typically placed in the lateral decubitus position. Rigid pelvic fixation using a peg board or bean bag is mandatory to ensure accurate assessment of component version and inclination during the reimplantation phase. Bony prominences must be meticulously padded, and the operative leg is prepped and draped free to allow for full range of motion testing.

Detailed Surgical Approach and Technique

The two-stage exchange arthroplasty requires two distinct, highly technical operative interventions separated by a period of systemic antimicrobial therapy.

Stage One Explantation and Debridement

The primary objective of the first stage is the absolute eradication of the biofilm and all non-viable tissue. The previous incision is utilized, extending it as necessary. An en bloc excision of the previous scar tract and any sinus tracts is performed.

Upon entering the joint, multiple tissue samples (typically 5 to 6) are obtained from distinct areas (capsule, interface membrane, acetabular floor) for microbiological culture and histopathological analysis.

Component extraction must be performed with care to preserve remaining host bone.
* Acetabular Extraction: Well-fixed uncemented cups are removed using curved explant blades (e.g., Explant system) to disrupt the bone-prosthesis interface while minimizing collateral bone loss.
* Femoral Extraction: If the stem is well-fixed, an Extended Trochanteric Osteotomy (ETO) is highly recommended. The ETO provides direct access to the cement mantle or porous coating. Ultrasonic tools and flexible osteotomes are utilized to remove all distal cement and restrictive plugs.

Following explantation, a radical synovectomy and debridement are executed. All necrotic bone, inflammatory pseudocapsule, and retained cement must be meticulously excised. The intramedullary canal is sequentially reamed and irrigated with pulsatile lavage using copious amounts of sterile saline and dilute antiseptic solutions.

Antibiotic Spacer Fabrication and Placement

An antibiotic-loaded PMMA spacer is inserted to maintain soft tissue tension, preserve dead space, and deliver high local concentrations of targeted antimicrobials. Spacers may be articulating or static. Articulating spacers improve patient mobility and facilitate the second-stage exposure, whereas static spacers are reserved for cases with massive bone loss or abductor deficiency where stability is compromised.

High-dose antibiotic cement is prepared, typically mixing 3 to 4 grams of Vancomycin and 3.6 grams of Tobramycin per 40-gram batch of PMMA. The antibiotics must be in powder form and heat-stable. The spacer is molded and inserted into the femur and acetabulum.

Interstage Management

Postoperatively, the patient undergoes a 6-week course of organism-specific intravenous or highly bioavailable oral antibiotics, directed by an infectious disease specialist. Following the completion of antibiotics, a "drug holiday" of 2 to 4 weeks is observed. Inflammatory markers (ESR, CRP) are trended. If markers normalize and the clinical picture is reassuring, a repeat joint aspiration is performed to confirm the eradication of infection prior to proceeding to Stage Two.

Stage Two Reimplantation

The second stage involves the removal of the spacer, a final debridement, and definitive arthroplasty reconstruction.

The joint is re-exposed, and the antibiotic spacer is extracted. Intraoperative frozen sections may be utilized to assess for persistent acute inflammation; greater than 5 to 10 PMNs per high-power field suggests ongoing infection, which may necessitate an abortive procedure and a repeat spacer placement.

If the frozen section is negative, the reconstruction proceeds.

Acetabular Reconstruction:
The acetabulum is sequentially reamed to bleeding host bone. The Paprosky classification guides reconstruction:
* Paprosky Type I and II defects are typically managed with highly porous hemispherical titanium components (jumbo cups) and multiple screws.
* Paprosky Type III defects require the restoration of the hip center utilizing highly porous metal augments (e.g., trabecular metal) to fill superior or medial voids. If column continuity is compromised (pelvic discontinuity), a custom triflange acetabular component or a cup-cage construct is mandated to provide mechanical stability.

Femoral Reconstruction:
Femoral bone loss is similarly addressed based on the Paprosky femoral classification.
* Minimal bone loss allows for the use of standard fully porous-coated cylindrical stems.
* Significant proximal bone loss with an intact diaphysis (Paprosky Type II or IIIA) is optimally managed with a modular fluted tapered titanium stem. These stems achieve diaphyseal fixation through rigid distal engagement, bypassing the proximal deficiency. The modularity allows for independent control of version, offset, and leg length.
* If an ETO was performed in the first stage, the osteotomy fragment is reduced around the new stem and secured with multiple cerclage cables.

The articulation is selected based on patient stability. Given the high risk of dislocation in revision surgery, large diameter femoral heads or dual mobility constructs are heavily favored. The wound is closed in multiple layers over closed suction drains to eliminate dead space and prevent hematoma formation.

Complications and Management

Hip reimplantation is a massive physiological insult and carries a complication profile significantly higher than primary arthroplasty. The meticulous execution of the surgical technique and rigorous perioperative optimization are required to mitigate these risks.

Common Complications in Hip Reimplantation

Post Operative Rehabilitation Protocols

The postoperative rehabilitation protocol following a two-stage hip reimplantation is highly individualized, dictated by the complexity of the reconstruction, the quality of the host bone, and the use of adjunctive techniques such as an ETO or massive structural allografting.

If rigid diaphyseal fixation is achieved with a modular fluted tapered stem and standard acetabular components are used without structural grafts, patients may be allowed weight-bearing as tolerated (WBAT) with an assistive device immediately postoperatively.

Conversely, if an ETO was performed, or if extensive uncontained defects were managed with augments or impaction grafting, weight-bearing is strictly restricted. Patients are typically placed on toe-touch weight-bearing (TTWB) or partial weight-bearing (PWB) for 6 to 8 weeks to allow for initial osteointegration and osteotomy consolidation.

Strict posterior or anterior hip precautions are enforced for a minimum of 12 weeks. Due to the extensive soft tissue dissection and prolonged operative times, patients are at a high risk for venous thromboembolism (VTE). Chemical prophylaxis (e.g., LMWH, Direct Oral Anticoagulants, or Aspirin depending on risk stratification) is mandated for 28 to 35 days postoperatively, alongside mechanical prophylaxis.

Summary of Key Literature and Guidelines

The management of PJI and the protocols for hip reimplantation are continuously evolving, guided by robust international consensus and high-quality literature.

The International Consensus Meeting (ICM) on Periprosthetic Joint Infection provides the most comprehensive, evidence-based algorithms for the diagnosis and management of PJI. The ICM criteria have largely superseded older diagnostic metrics, incorporating advanced biomarkers such as alpha-defensin and next-generation sequencing for culture-negative infections.

Zimmerli et al. (New England Journal of Medicine, 2004) established the foundational framework for the algorithmic approach to PJI, delineating the strict indications for DAIR versus two-stage exchange based on symptom duration and implant stability.

Furthermore, the Parvizi criteria (modified MSIS criteria) remain the gold standard for defining the presence of PJI, utilizing a scoring system based on major criteria (sinus tract, two positive cultures) and minor criteria (elevated CRP/ESR, synovial WBC, PMN%, positive histology). Adherence to these standardized guidelines ensures optimal patient selection, appropriate surgical timing, and the highest probability of infection eradication and functional restoration in hip reimplantation surgery.